Jinshan Michael Chen
Pfizer (United States)(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Wnt/β-catenin signaling in development and cancer, Pneumocystis jirovecii pneumonia detection and treatment, Tuberculosis Research and Epidemiology, Alzheimer's disease research and treatments
Most-Cited Works
- → Pyridone Methylsulfone Hydroxamate LpxC Inhibitors for the Treatment of Serious Gram-Negative Infections(2012)97 cited
- → Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections(2011)97 cited
- → Discovery of a Highly Selective Glycogen Synthase Kinase‐3 Inhibitor (PF‐04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET Neuroimaging(2016)90 cited
- → Ru/Ni Dual Catalytic Desulfinative Photoredox Csp2–Csp3 Cross-Coupling of Alkyl Sulfinate Salts and Aryl Halides(2017)73 cited
- → Discovery of Dap-3 Polymyxin Analogues for the Treatment of Multidrug-Resistant Gram-Negative Nosocomial Infections(2013)55 cited
- → Structural Basis for Achieving GSK-3β Inhibition with High Potency, Selectivity, and Brain Exposure for Positron Emission Tomography Imaging and Drug Discovery(2019)44 cited
- → Novel 3-O-carbamoyl erythromycin A derivatives (carbamolides) with activity against resistant staphylococcal and streptococcal isolates(2013)21 cited